Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal decision profile

International Journal of Pharmaceutics

Pharmacology, Toxicology and Pharmaceutics · Materials Science
Elsevier BVNetherlandspISSN 0378-5173eISSN 1873-3476
Checking system sharing availability.Visit homepage
Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
6.4

Journal Metrics Score 2026 · 2021–2024 window citedness 5.73.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
75 daysmedian

Middle 50%: 56–90 days

100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$4,050

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
6.42026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#2 / 1,042LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
25.1%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
1.45MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
75 daysIQR 56–90 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
1099 / yr2021–2024 AVG
Field-normalized top 10% share25.1%

1105 of 4,396 works · same type, year & subfield

Field-normalized top 1% share1.2%

52 works · same type, year & subfield

Median FWCI1.45×

Above field-year expectation

Source output rank#2

of 1,042 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.45, so its typical recent paper runs about 45% above its field benchmark.

What does Top 10% Share mean?

25.1% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

9632016
9492017
8712018
9302019
10682020
11152021
10112022
10312023
12392024
12382025

Recent work-type mix

4,396 OpenAlex works · 2021–2024

Article96.6%
Paratext1.8%
Erratum1.2%
Editorial0.2%
Retraction0.2%
Review0.1%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works
NanoparticlesExcipientsDrug Delivery SystemsNeoplasmsLiposomesChitosanTechnology, PharmaceuticalDrug LiberationAntineoplastic Agents

Leading OpenAlex topics

2021–2024 works
Drug Solubulity and Delivery Systems423
Advancements in Transdermal Drug Delivery312
Nanoparticle-Based Drug Delivery242
Advanced Drug Delivery Systems234
Inhalation and Respiratory Drug Delivery200
RNA Interference and Gene Delivery143
Nanoplatforms for cancer theranostics138
3D Printing in Biomedical Research133
Protein purification and stability83
Diverse Scientific and Economic Studies78
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 4,396 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Recommended alternatives

Candidates share the leading OpenAlex topic, then subfield or field when needed, and are ranked by current Journal Metrics Score.

OpenAlex topic-neighbor model · Preview
Asian Journal of Pharmaceutical SciencesTopic-neighbor alternative7.1Metrics Score146dIQR 102–193dSubmission → acceptance$—Cost*Journal of Pharmaceutical InvestigationTopic-neighbor alternative5.7Metrics Score—Submission → acceptance$$$Cost*Aaps PharmscitechTopic-neighbor alternative5.3Metrics Score96dIQR 73–123dSubmission → acceptance$$$Cost*European Journal of Pharmaceutics and BiopharmaceuticsTopic-neighbor alternative5.1Metrics Score96dIQR 69–141dSubmission → acceptance$$$Cost*European Journal of Pharmaceutical SciencesTopic-neighbor alternative4.2Metrics Score83dIQR 54–109dSubmission → acceptance$$Cost*International Journal of Pharmaceutics-XTopic-neighbor alternative3.5Metrics Score—Submission → acceptance$$Cost*

More alternative journals

Pharmaceutical Development and TechnologyDrug Development and Industrial PharmacyActa PharmaceuticaIndian Journal of Pharmaceutical Education and ResearchTurkish Journal of Pharmaceutical SciencesInternational Journal of Pharmaceutical Investigation

* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Pharmaceutical ScienceQ1
BiomaterialsQ1

Considering submitting to International Journal of Pharmaceutics?

Use your manuscript title to find AI-ranked journals with related recent work, fit reasons, risks, and submission strategy.

Match my manuscript →
Q1
Subfield Quartile
B2
CAS Block

Ranking and source check

#13
of 193 Pharmacology field journals
#13
among Q1 Pharmacology journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

View all Pharmacology journals →View Q1 Pharmacology journals →

Topics where this journal appears in PubMed searches

These topic links come from cached PubMed keyword snapshots where International Journal of Pharmaceutics appears among matched journals.

nanoparticle based drug delivery22

Journal Details

OpenAlex Works
27,848
H-Index
300
Fully Open Access
No
Recent OA Works
4,004
Subject Areas
Pharmaceutical SciencePharmaceutical SciencePharmaceutical ScienceBiomaterials

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Related Guides

Publishing Guide
How to Choose the Right Journal for Your Research Paper
15 min read
Publishing Guide
Journal Selection Criteria: Essential Factors for Choosing the Right Publication Venue
20 min read
Publishing Safety
Journal Indexing Verification Guide
18 min read
Back to Search